Technical Analysis for ERYP - Erytech Pharma S.A.

Grade Last Price % Change Price Change
grade D 7.165 -1.81% -0.13
ERYP closed down 1.81 percent on Friday, January 17, 2020, on 1.66 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical ERYP trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Lizard Bearish Bearish Day Trade Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction -1.81%
NR7 Range Contraction -1.81%
NR7-2 Range Contraction -1.81%
Wide Bands Range Expansion -1.81%
Gapped Up Strength -1.81%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death. The Company's subsidiary is Erytech Pharma, Inc in the USA which legal existence began in April 9, 2014.
Medicine Biopharmaceutical Cancer Clinical Medicine Antineoplastic Drugs Leukemia Acute Lymphoblastic Leukemia Asparaginase Medicinal Products

Is ERYP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 11.89
52 Week Low 3.9458
Average Volume 4,209
200-Day Moving Average 6.94
50-Day Moving Average 5.41
20-Day Moving Average 6.44
10-Day Moving Average 7.17
Average True Range 0.45
ADX 38.47
+DI 47.73
-DI 13.38
Chandelier Exit (Long, 3 ATRs ) 6.72
Chandelier Exit (Short, 3 ATRs ) 5.85
Upper Bollinger Band 8.71
Lower Bollinger Band 4.16
Percent B (%b) 0.66
BandWidth 70.67
MACD Line 0.57
MACD Signal Line 0.56
MACD Histogram 0.0115
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.54
Resistance 3 (R3) 8.69 8.39 8.31
Resistance 2 (R2) 8.39 8.04 8.31 8.23
Resistance 1 (R1) 7.78 7.82 7.62 7.62 8.16
Pivot Point 7.47 7.47 7.39 7.39 7.47
Support 1 (S1) 6.86 7.12 6.71 6.71 6.17
Support 2 (S2) 6.56 6.90 6.48 6.10
Support 3 (S3) 5.95 6.56 6.02
Support 4 (S4) 5.79